254
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Risk factors for recurrent ectopic pregnancy following single-dose methotrexate treatment

ORCID Icon, , , , &
Pages 294-298 | Received 26 Dec 2018, Accepted 23 May 2019, Published online: 17 Jun 2019

References

  • Farquhar CM. Ectopic pregnancy. Lancet. 2005;366:583–591.
  • Centers for Disease Control and Prevention (CDC). Ectopic pregnancy mortality – Florida, 2009–2010. MMWR Morb Mortal Wkly Rep. 2012;61:106–109.
  • Marion LL, Meeks GR. Ectopic pregnancy: history, incidence, epidemiology, and risk factors. Clin Obstet Gynecol. 2012;55:376–386.
  • Goldner TE, Lawson HW, Xia Z, et al. Surveillance for ectopic pregnancy-United States, 1970–1989. MMWR CDC Surveill Summ. 1993;42:73–85.
  • Butts S, Sammel M, Hummel A, et al. Risk factors and clinical features of recurrent ectopic pregnancy: a case control study. Fertil Steril. 2003;80:1340–1344.
  • Zhang D, Shi W, Li C, et al. Risk factors for recurrent ectopic pregnancy: a case-control study. BJOG: Int J Obstet Gy. 2016;123: 82–89.
  • Skjeldestad FE, Hadgu A, Eriksson N. Epidemiology of repeat ectopic pregnancy: a population-based prospective cohort study. Obstet Gynecol. 1998;91:129–135.
  • Schoen JA, Nowak RJ. Repeat ectopic pregnancy: a 16-year clinical survey. Obstet Gynecol. 1975;45:542–546.
  • Hallatt JG. Repeat ectopic pregnancy: a study of 123 consecutive cases. Am J Obstet Gynecol. 1975;122:520–524.
  • Sandvei R, Bergsjø P, Ulstein M, et al. Repeat ectopic pregnancy. A twenty-year hospital survey. Acta Obstet Gynecol Scand. 1987;66:35–40.
  • Stulberg DB, Zhang JX, Lindau ST. Socioeconomic disparities in ectopic pregnancy: predictors of adverse outcomes from Illinois hospital-based care, 2000-2006. Matern Child Health J. 2011;15:234–241.
  • Creanga AA, Shapiro-Mendoza CK, Bish CL, et al. Trends in ectopic pregnancy mortality in the United States: 1980–2007. Obstet Gynecol. 2011;117:837–843.
  • Ellaithy M, Asiri M, Rateb A, et al. Prediction of recurrent ectopic pregnancy: a five-year follow-up cohort study. Eur J Obstet Gynecol Reprod Biol. 2018;225:70–78.
  • Hurrell A, Reeba O, Funlayo O. Recurrent ectopic pregnancy as a unique clinical sub group: a case control study. Springerplus 2016;5:265.
  • Yao M, Tulandi T. Surgical and medical management of tubal and non-tubal ectopic pregnancies. Curr Opin Obstet Gynecol. 1998;10:371–374.
  • Yao M, Tulandi T. Current status of surgical and nonsurgical management of ectopic pregnancy. Fertil Steril. 1997;67:421–433.
  • Li C, Meng CX, Zhao WH, et al. Risk factors for ectopic pregnancy in women with planned pregnancy: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2014;181:176–182.
  • Barnhart K, van Mello NM, Bourne T, et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril. 2011;95:857–866.
  • American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 193: tubal ectopic pregnancy. Obstet Gynecol. 2018;131:e91–e103.
  • Centers for Disease Control and Prevention (CDC). Ectopic pregnancy – United States, 1990–1992. MMWR Morb Mortal Wkly Rep. 1995;44:46–48.
  • ten Broek RP, Issa Y, van Santbrink EJ, et al. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ. 2013;347:f5588.
  • Berek JS, Hillard PA, Novak’s gynecology. 12th ed. Baltimore (MD): Williams and Wilkins 1996;495–496.
  • Refaat B, Dalton E, Ledger WL. Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Reprod Biol Endocrinol. 2015;13:30.
  • Kuroda K, Takeuchi H, Kitade M, et al. Assessment of tubal disorder as a risk factor for repeat ectopic pregnancy after laparoscopic surgery for tubal pregnancy. J Obstet Gynaecol Res. 2009;35:520–524.
  • Joesoef MR, Westrom L, Reynolds G, et al. Recurrence of ectopic pregnancy: the role of salpingitis. Am J Obstet Gynecol. 1991;165:46–50.
  • Cohen A, Almog B, Cohen Y, et al. The role of HCG increment in the 48h prior to methotrexate treatment as a predictor for treatment success. Eur J Obstet Gynecol Reprod Biol. 2017;211:103–107.
  • Levin G, Saleh NA, Haj-Yahya R, et al. Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment. Int J Gynecol Obstet. 2018;141:70–73.
  • Levin G, Rottenstreich A. The predictive role of serum hCG 0–4 days after methotrexate treatment for ectopic pregnancy is yet to be determined. Int J Gynecol Obstet. 2018;143:260.
  • Levin G, Dior U, Shushan A, et al. Early prediction of the success of methotrexate treatment success by 24‐hour pretreatment increment in HCG and day 1–4 change in HCG. Reprod Biomed Online. [cited 2019 Feb 27]. DOI:10.1016/j.rbmo.2019.02.005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.